Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
Here, Kristoffer Petersson, MRC Investigator and Group Leader of FLASH Radiation, enlightens us to the benefits of this promising new radiotherapy technique.
Gwo-shyh Song, Associate Professor at the National Taiwan University and Global Aqua Survey Ltd, walks us through his high-resolution seabed geophysical survey research around offshore areas in Taiwan.
Jason W. Loxterkamp and Pamela J. Lein from University of California, Davis, explore the therapeutic potential of psychedelic drugs in patients with psychiatric disorders.
The University of Manchester found that tinnitus could be a COVID-19 symptom - some patients of the virus are reporting a loss in hearing and ringing of the ears.
Stephen O’Sullivan, Head of Enforcement Business Development and Sales at Siemens Mobility, discusses how the pandemic has affected plans for Clean Air Zones (CAZs).
Logan Finucan, Access Partnership, explains how the European Commission has launched the process towards the adoption of two adequacy decisions for personal dataflows to the UK.
Professor of Mathematics Education Ilana Seidel Horn offers a compelling insight into how teachers individually navigate their field through pedagogical reasoning and responsibility.
Raimund Bleischwitz from University College London, Bartlett School of Environment, Energy and Resources (UCL BSEER), discusses systems thinking for net zero carbon and a circular economy.
The Dexamethasone steroid has been used across the globe to help treat COVID-19 in the ICU - leading to atleast one million survivors of hospitalisation from the virus.
Sarah Woolnough, Chief Executive of Asthma UK and the British Lung Foundation, discusses the UK’s toxic air crisis, the invisible threat of air pollution, and outlines how policymakers must protect people’s health and create a fairer, healthier society.
In a study of over 32,000 people, a US trial found the AstraZeneca vaccine was 100% effective against deaths caused by COVID-19 - the vaccine did not show any connection to blood clots.
